Ovarian cancer patients treated with cisplatin with high RECQL4 expression had shorter OS than those with low RECQL4 expression according to the online analysis website Kaplan–Meier Plotter (Supplementary Figure S1I). Here, RECQL4 is linked to ovarian cancer.